Register now for Fin24 Dashboard and get access to portfolios, watchlists, financial comparison tools, and a whole lot more to help you achieve your financial goals.

Data provided by McGregor BFA
All data is delayed
Loading...
Where am I? Home

View company snapshot for more news and data.

Mediclinic International (JSE MDC)

Last
ZAR 36.90
Change:
Arrow 0.07 (0.19%)
52 Week Range
29.01 41.99

Previous Close36.97
Open37.00
Bid to Buy36.89 x 0
Offer to Sell36.90 x 0
Day's Range:36.65 - 37.20
Volume: 536 195
Market Cap:24.07bn
P/E Ratio:18.93
EPS: 117.70
Dividend:78.00
Dividend yield:1.89%
Shares Outstanding:652.32m
Data provided by McGregor BFA All JSE data fields are delayed by 15 minutes.
PE, EY and DY are calculated by McGregor BFA and are therefore not the official JSE Market Statistics. The calculation/derivation may include underlying JSE data.

Sector Peers:

Health Care > Health Care Equipment & Services
Symbol Company Name d m y Today's Change Market Cap
LHC Life Healthcare G... [Loading...] 0.45 (1.60%) 29.81bn
NTC Netcare Limited [Loading...] -0.05 (-0.32%) 22.35bn
ACT Afrocentric Inv C... [Loading...] 0.00 (0.00%) 883.13m
ACTP Afrocentric Inv C... [Loading...] 0.00 (0.00%) 166.38m

Company Directors

whoswho
DirectorImage

Dr Mamphela Aletta Ramphele

Non-Executive Director

View

DirectorImage

Mr Matthys Hendrik (Thys) Visser

Non-Executive Director

View

DirectorImage

Mr Albert Anton Raath

Independent Non-Executive Director

View

DirectorImage

Ms Zodwa Penelope Manase

Independent Non-Executive director

View

DirectorImage

Mr Koert Hendrik Stefanus Pretorius

Chief Executive Officer: Medi-Clinic Southern Africa

View

More directors...

$JSEMDC on Twitter

Twitter icon

Join the Fin24.com conversation about JSE-listed stock Mediclinic International by using $JSEMDC every time you tweet.

Loading..

Guru Analysis

Only Premium Account holders can view Guru Scorecard ratings and 10 Stock Models. Sign In or Register now for access!
Based OnStrategy GuruScore at In 10 Stock Model Portfolio Date Changed Rating Change
Peter LynchP/E/Growth Investor Premium Content Premium Content - -
Motley FoolSmall-Cap Growth Investor Premium Content Premium Content - -
Benjamin GrahamValue Investor Premium Content Premium Content - -
David DremanContrarian Investor Premium Content Premium Content - -
Martin ZweigGrowth Investor Premium Content Premium Content - -
Kenneth FisherPrice/Sales Investor Premium Content Premium Content - -
James P. O'ShaughnessyGrowth/Value Investor Premium Content Premium Content 25/10/2011 Upgrade
Warren BuffettPatient Investor Premium Content Premium Content - -
John NeffLow PE Investor Premium Content Premium Content - -
Joseph PiotroskiBook/Market Investor Premium Content Premium Content - -
Joel GreenblattEarnings Yield Investor Premium Content Premium Content - -
Loading...